Skip to main content
logo
ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS · Delayed Price · Currency is USD
4.000
-1.000 (-20.00%)
Jul 28, 2026, 9:32 AM EST

ZIVO Bioscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
0.210.160.03--0.02
Revenue Growth
164.52%468.61%----
Gross Profit
0.070.050.01--0.02
Operating Income
-8.46-13.36-7.26-8.73-8.65-8.56
Net Income
-8.49-13.38-7.78-8.75-8.76-9.11
Earnings Per Share
-2.27-4.23-4.60-5.57-6.89-10.76
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
0.061.540.271.88.90.14
Total Debt
0.820.250.350.450.265.36
Net Cash (Debt)
-0.761.29-0.071.358.65-5.22
Net Cash Growth
----84.34%--
Net Cash Per Share
-0.200.41-0.040.866.80-6.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-3.08-4.31-5.8-7.1-6.8-2.59
Free Cash Flow
-3.08-4.31-5.8-7.1-6.8-2.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
31.67%31.14%41.99%--100.00%
Operating Margin
-4045.65%-8498.85%-26267.68%---42778.38%
Pretax Margin
-4059.73%-8513.44%-28127.25%---45528.64%
Profit Margin
-4059.73%-8513.44%-28127.25%---45528.64%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
99.31484.9787.64--3077.41